Risk of SARS-CoV-2 infection during the Omicron surge in patients on dialysis: The role of antibody responses and vaccine doses

• Among US adults with kidney failure receiving dialysis, risk for SARS-CoV-2 infection during the Omicron-dominant period was higher among patients without vaccination and with 1–2 doses compared with 3 doses of mRNA vaccines.
• Irrespective of vaccine doses, risk for infection was higher among patients with low circulating levels of anti–SARS-CoV-2 antibodies.

Decision model favors left atrial appendage occlusion over oral anticoagulants for stroke prevention in patients at highest risk for bleeding

A decision model found that the relative clinical benefit of left atrial appendage occlusion (LAAO) and oral anticoagulants (OAC) in patients with atrial fibrillation depends on the patients’ baseline risks for stroke and bleeding. LAAOs were found to be the preferred strategy in those with the highest bleeding risk. This benefit became less certain with increasing risk for ischemic stroke and decreasing bleeding risk. The findings are published in Annals of Internal Medicine.

The AABB releases clinical practice guidelines for the appropriate use of COVID-19 convalescent plasma

The Association for the Advancement of Blood and Biotherapies (AABB) has released clinical practice guidelines for the appropriate use of COVID-19 convalescent plasma (CCP) in hospital and outpatient settings. Based on two living systematic reviews of randomized controlled trials (RCTs), the guidelines provide five specific recommendations for treating patients with COVID-19 and suggest that CCP is most effective when transfused with high neutralizing titers to infected patients early after symptom onset. The guidelines are published in Annals of Internal Medicine.

Radiation Oncology Expert Joins Cedars-Sinai Cancer

Marc Botnick, MD, a board-certified radiation oncologist with more than 20 years of experience managing all cancer types, has been named regional medical director for Radiation Oncology at Cedars-Sinai Cancer. His primary clinical practice site will be at Cedars-Sinai Tarzana Radiation Oncology, but he will work closely with physicians throughout the enterprise.

AASLD Foundation Funds Over $1.5 Million in Hepatology Research and Career Development in 2022

The American Association for the Study of Liver Diseases (AASLD) Foundation, the largest medical society supporter of liver disease research and training in the United States, today announced its combined investment of over $1.5 million in Research and Career Development Awards, Abstract Awards, Emerging Liver Scholars (ELS) Program for medical residents and its new Emerging Liver Advanced Practice Provider (APP) Program.

The 2022 award recipients — selected from a highly competitive applicant pool — demonstrate both exceptional aptitude and deep interest in liver disease research and treatment. Their work will further advance the mission of the AASLD Foundation and hepatology as a medical specialty.

Cedars-Sinai Lung Transplant Outcomes Rated Outstanding

A new report on lung transplantation success rates confirms that Cedars-Sinai patients experienced one-year survival outcomes of 91.49%, an achievement above the national average of 89.46%.

Seven Hackensack Meridian Health Medical Centers Nationally Recognized for their Commitment to Providing High-Quality Heart Failure Care

Seven Hackensack Meridian Health medical centers have received American Heart Association Get With The Guidelines® – Heart Failure Quality Achievement Awards. The awards recognize the medical centers’ commitment to improving outcomes for patients with heart failure, reducing patient readmissions and providing more healthy days at home.

UC San Diego Named 5th Best Public University by Academic Ranking of World Universities

The University of California San Diego has been ranked 5th among the nation’s best public universities for its award-winning faculty and alumni, academic performance and impactful research. The new 2022 Academic Ranking of World Universities (ARWU) ranking was released today by ShanghaiRanking Consultancy, which also named UC San Diego 16th among colleges in the nation and 21st in the world.

UCI-led study shows Rhodiola rosea root might be beneficial for managing type 2 diabetes

A team of researchers led by the University of California, Irvine has discovered that treatment with an extract from the roots of the Rhodiola rosea plant might be effective for helping manage type 2 diabetes, showing promise as a safe and effective non-pharmaceutical alternative. The study, recently published online in Scientific Reports, found that in a mouse model of human type 2 diabetes, Rhodiola rosea lowered fasting blood sugar levels, improved response to insulin injections, modulated the composition of bacteria in the gastrointestinal tract and decreased several biomarkers of inflammation.

University of Pittsburgh Library System Receives $1 Million Dollar Grant from the Henry L. Hillman Foundation for August Wilson Archive Outreach and Engagement

The University of Pittsburgh Library System has received a $1 million grant from the Henry L. Hillman Foundation. The grant will support the preparation of the August Wilison Archive, the collected history of one of America’s greatest playwrights. The grant is the biggest in the history of the Library System.

Precision health perspectives

In February, UCI launched the Institute for Precision Health, a campus-wide, interdisciplinary endeavor that merges UCI’s powerhouse health sciences, engineering, machine learning, artificial intelligence, clinical genomics and data science capabilities. The objective is to identify, create and deliver the most effective health and wellness strategy for each individual person and, in doing so, confront the linked challenges of health equity and the high cost of care.

New educational alliance between the American Heart Association and the Cardiovascular Research Foundation announced

Two leaders in cardiovascular disease science, research and education, the American Heart Association (Association) and the Cardiovascular Research Foundation (CRF), are joining forces to strengthen and expand educational opportunities focused on advancing the latest research in cardiovascular disease and interventional therapies. The new alliance to produce joint education programs begins immediately with the organizations’ annual scientific meetings this fall. The Association will present educational programming from its annual Scientific Sessions at TCT, and CRF will deliver educational programming from its annual scientific symposium Transcatheter Cardiovascular Therapeutics (TCT) at the Association’s Scientific Sessions, beginning with TCT 2022, September 16-19 in Boston, and the Association’s Scientific Sessions 2022, November 5-7 in Chicago, respectively.

Visual Abstract: Standard vs Enhanced Self-Measurement of Blood Pressure Paired With Smartphone Application

  Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3355?guestAccessKey=fd9d8a9c-2d02-4b28-9e0d-0e4b4c9afdf9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081522   Visual Abstract…

Research results on benefits of camp on kids with ventilators

The study, “The Effect of an Overnight Summer Camp on the Quality of Life for Individuals Who Require Ventilatory Support,” appears in in the “Pediatric Physical Therapy” journal. The team, which included graduate students from LVC, has found that attending summer camp boosts the quality of life for children using ventilators. And the more years such children attend summer camp, the better their quality of life becomes, according to the study.

Mayo Clinic research shows bebtelovimab to be a reliable option for treating COVID-19 in era of BA.2, other subvariants

Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron variant of COVID-19, is a reliable option to treat BA.2 and other COVID-19 subvariants. The findings of their multisite, retrospective study involving 3,607 high-risk patients appear in the Journal of Infectious Diseases.